ARALAST NP®

Aralast NP®

FDA INDICATION: Aralast NP is an alpha-1 proteinase inhibitor (human) indicated for chronic augmentation therapy in adults with clinically evident emphysema due to severe congenital deficiency of alpha-1 antitrypsin deficiency. Package Insert

FORM: Lyophilized

DISTRIBUTOR: Shire

ROUTE OF ADMINISTRATION: Intravenous

DOSAGE STRENGTH: 0.5 grams, 1 gram

DILUENT SIZE: 25 mL (0.5 grams), 50 mL (1 gram)

DOSE: 60 mg/kg body weight administered once weekly by intravenous infusion

MIXING DEVICE: Double-ended transfer needle

STORAGE: Store at temperatures not to exceed 25°C (77°F). Do not freeze. Protect from light.

HALF-LIFE: 4.7 (± 2.7) days

OTHER WEBSITES: Ruleitout